featured
Bortezomib-Based Induction, High-Dose Melphalan, and Lenalidomide Maintenance in Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bortezomib-Based Induction, High-Dose Melphalan and Lenalidomide Maintenance in Myeloma Up to 70 Years of Age
Leukemia 2020 Jul 20;[EPub Ahead of Print], EK Mai, K Miah, U Bertsch, J Dürig, C Scheid, KC Weisel, C Kunz, M Munder, HW Lindemann, M Merz, D Hose, A Jauch, A Seckinger, S Luntz, S Sauer, S Fuhrmann, P Brossart, A Elmaagacli, M Goerner, H Bernhard, M Hoffmann, MS Raab, IW Blau, M Hänel, A Benner, HJ Salwender, H GoldschmidtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.